425: Berry Global and Glatfelter Achieve Regulatory Milestone in Proposed Transaction

Sentiment:

Merger Announcement


Berry Global and Glatfelter announced the expiration of the HSR Act waiting period, marking a regulatory milestone in their proposed transaction to combine Berry's Health, Hygiene and Specialties segment with Glatfelter.

Summary

  • Berry Global Group, Inc. and Glatfelter Corporation announced that the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act has expired.
  • This marks a regulatory milestone in the proposed transaction where Berry will spin-off and merge its Health, Hygiene and Specialties segment's Global Nonwovens and Films business (HHNF) with Glatfelter.
  • The definitive agreement for this Reverse Morris Trust transaction was previously announced on February 7, 2024.
  • The transaction aims to create a leading, publicly-traded company in the specialty materials industry.
  • The deal is expected to close in the second half of calendar 2024, pending Glatfelter shareholder approval and customary closing conditions.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the announcement confirms progress in a significant strategic transaction. The expiration of the HSR waiting period reduces uncertainty, but the deal is still subject to shareholder approval and other closing conditions.

Positives

  • The expiration of the HSR Act waiting period indicates progress towards completing the proposed transaction.
  • The merger is expected to create a leading, publicly-traded company in the specialty materials industry.
  • The combined company will benefit from the strengths of both Berry Global and Glatfelter.
  • Glatfelter's 2023 revenue was $1.4 billion with approximately 2,980 employees worldwide.

Risks

  • The transaction is subject to approval by Glatfelter shareholders.
  • The transaction is subject to customary closing conditions.
  • There are risks related to potential litigation brought in connection with the proposed transaction.
  • The anticipated tax treatment of the proposed transaction may not be obtained.
  • The integration of the combined company may be more difficult, time consuming or costly than expected.
  • The announcement, pendency or completion of the proposed transaction may affect the ability of the parties to retain customers and key personnel.

Future Outlook

The transaction is expected to close in the second half of calendar 2024, subject to Glatfelter shareholder approval and customary closing conditions. The combined company aims to be a leader in the specialty materials industry.

Industry Context

The transaction reflects a trend towards consolidation and specialization in the specialty materials industry, as companies seek to gain scale and improve their competitive positioning.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerNACurt Begle (current President of Berry's Health, Hygiene & Specialties Division)Upon closing of the transactionLeadership of the combined company
Executive Vice President, Chief Financial Officer & TreasurerNAJames M. Till (current Executive Vice President and Controller of Berry)Upon closing of the transactionLeadership of the combined company
Executive Vice President, Chief Operating OfficerNATarun Manroa (current Executive Vice President and Chief Strategy Officer of Berry)Upon closing of the transactionLeadership of the combined company

Stakeholder Impact

  • Shareholders of Glatfelter will vote on the proposed transaction.
  • Employees of both Berry Global and Glatfelter may experience changes as a result of the merger.
  • Customers of both companies may benefit from the combined capabilities and offerings.

Next Steps

  • Glatfelter shareholders need to approve the transaction.
  • The companies need to satisfy customary closing conditions.
  • Spinco expects to file a registration statement in connection with its separation from Berry.

Key Dates

DateDescription
January 4, 2024Berry's definitive proxy statement for the 2024 Annual Meeting of Stockholders was filed with the SEC.
February 7, 2024Berry and Glatfelter entered into a definitive agreement for the spin-off and merger of Berry's HHNF business with Glatfelter.
March 26, 2024Glatfelter's proxy statement for the 2024 Annual Meeting of Shareholders was filed with the SEC.
April 17, 2024Berry and Glatfelter announced the achievement of a regulatory milestone with the expiration of the HSR Act waiting period.
Second half of calendar 2024Expected closing date of the transaction, subject to shareholder approval and customary closing conditions.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.